Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapy

The Importance of Recognizing Pain in Patients With Autosomal Dominant Polycystic Kidney Disease

“…Besides identifying patients with ADPKD-related concerns, questionnaires could also have an important role in selecting patients for these more invasive treatment options. In a publication by Barten et al, 15 the PLD-Q was used to determine a threshold for active treatment in patients with polycystic liver disease. The authors analyzed the PLD-Q scores of around 200 patients with polycystic liver disease and determined that, when a patient reached a PLD-Q score of ≥32, the patient may benefit from active treatment, such sclerotherapy, surgical intervention, or the start of somatostatin analogues (which are known to decrease liver and kidney volume).…”